APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Preparation

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Blood Preparation Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchBlood Preparation Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Preparation Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Blood Preparation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Preparation Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Preparation Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Blood Preparation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Blood Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Preparation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Blood Preparation market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Blood Preparation market include Pfizer, GlaxoSmithKline, Baxter Healthcare Corp, AstraZeneca, Sanofi Aventis, Leo Pharma, Celgene Corporation and Bristol-Myers Squibb Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Blood Preparation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Preparation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Preparation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Blood Preparation market size, projected growth trends, production technologies, key applications, and end-use industries.

Blood Preparation Segment by Company

Pfizer

GlaxoSmithKline

Baxter Healthcare Corp

AstraZeneca

Sanofi Aventis

Leo Pharma

Celgene Corporation

Bristol-Myers Squibb Company

Blood Preparation Segment by Type

Blood Components

Whole Blood

Blood Derivatives

Blood Preparation Segment by Application

Thrombocytosis

Angina Blood Vessel Complications

Renal Impairment

Pulmonary Embolism

Others

Blood Preparation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Blood Preparation status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Blood Preparation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blood Preparation significant trends, drivers, influence factors in global and regions.

6. To analyze Blood Preparation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Preparation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Preparation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Preparation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Blood Preparation market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Preparation industry.

Chapter 3: Detailed analysis of Blood Preparation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Blood Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Blood Preparation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blood Preparation Industry Trends Table 2. Blood Preparation Industry Drivers Table 3. Blood Preparation Industry Opportunities and Challenges Table 4. Blood Preparation Industry Restraints Table 5. Global Blood Preparation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blood Preparation Revenue Share by Company (2021-2026) Table 7. Global Blood Preparation Sales Volume by Company (k units) & (2021-2026) Table 8. Global Blood Preparation Sales Volume Share by Company (2021-2026) Table 9. Global Blood Preparation Average Price (US$/unit) of Company (2021-2026) Table 10. Global Blood Preparation Company Ranking, (2024-2026) & (USD Million) Table 11. Global Blood Preparation Key Company Manufacturing Base & Headquarters Table 12. Global Blood Preparation Company, Product Type & Application Table 13. Global Blood Preparation Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Blood Preparation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Blood Components Table 18. Significant Companies of Whole Blood Table 19. Significant Companies of Blood Derivatives Table 20. Global Blood Preparation Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Blood Preparation Sales Volume by Type (2021-2026) & (k units) Table 22. Global Blood Preparation Sales Volume by Type (2027-2032) & (k units) Table 23. Global Blood Preparation Sales Volume Share by Type (2021-2026) Table 24. Global Blood Preparation Sales Volume Share by Type (2027-2032) Table 25. Global Blood Preparation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Blood Preparation Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Blood Preparation Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Blood Preparation Sales Value Share by Type (2021-2026) Table 29. Global Blood Preparation Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Thrombocytosis Table 31. Significant Companies of Angina Blood Vessel Complications Table 32. Significant Companies of Renal Impairment Table 33. Significant Companies of Pulmonary Embolism Table 34. Significant Companies of Others Table 35. Global Blood Preparation Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Blood Preparation Sales Volume by Application (2021-2026) & (k units) Table 37. Global Blood Preparation Sales Volume by Application (2027-2032) & (k units) Table 38. Global Blood Preparation Sales Volume Share by Application (2021-2026) Table 39. Global Blood Preparation Sales Volume Share by Application (2027-2032) Table 40. Global Blood Preparation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Blood Preparation Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Blood Preparation Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Blood Preparation Sales Value Share by Application (2021-2026) Table 44. Global Blood Preparation Sales Value Share by Application (2027-2032) Table 45. Global Blood Preparation Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Blood Preparation Sales by Region (2021-2026) & (k units) Table 47. Global Blood Preparation Sales Market Share by Region (2021-2026) Table 48. Global Blood Preparation Sales by Region (2027-2032) & (k units) Table 49. Global Blood Preparation Sales Market Share by Region (2027-2032) Table 50. Global Blood Preparation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Blood Preparation Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Blood Preparation Sales Value Share by Region (2021-2026) Table 53. Global Blood Preparation Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Blood Preparation Sales Value Share by Region (2027-2032) Table 55. Global Blood Preparation Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Blood Preparation Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Blood Preparation Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Blood Preparation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Blood Preparation Sales by Country (2021-2026) & (k units) Table 60. Global Blood Preparation Sales Market Share by Country (2021-2026) Table 61. Global Blood Preparation Sales by Country (2027-2032) & (k units) Table 62. Global Blood Preparation Sales Market Share by Country (2027-2032) Table 63. Global Blood Preparation Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Blood Preparation Sales Value Market Share by Country (2021-2026) Table 65. Global Blood Preparation Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Blood Preparation Sales Value Market Share by Country (2027-2032) Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer Blood Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Pfizer Blood Preparation Product Portfolio Table 71. Pfizer Recent Development Table 72. GlaxoSmithKline Company Information Table 73. GlaxoSmithKline Business Overview Table 74. GlaxoSmithKline Blood Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Blood Preparation Product Portfolio Table 76. GlaxoSmithKline Recent Development Table 77. Baxter Healthcare Corp Company Information Table 78. Baxter Healthcare Corp Business Overview Table 79. Baxter Healthcare Corp Blood Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Baxter Healthcare Corp Blood Preparation Product Portfolio Table 81. Baxter Healthcare Corp Recent Development Table 82. AstraZeneca Company Information Table 83. AstraZeneca Business Overview Table 84. AstraZeneca Blood Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. AstraZeneca Blood Preparation Product Portfolio Table 86. AstraZeneca Recent Development Table 87. Sanofi Aventis Company Information Table 88. Sanofi Aventis Business Overview Table 89. Sanofi Aventis Blood Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Sanofi Aventis Blood Preparation Product Portfolio Table 91. Sanofi Aventis Recent Development Table 92. Leo Pharma Company Information Table 93. Leo Pharma Business Overview Table 94. Leo Pharma Blood Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Leo Pharma Blood Preparation Product Portfolio Table 96. Leo Pharma Recent Development Table 97. Celgene Corporation Company Information Table 98. Celgene Corporation Business Overview Table 99. Celgene Corporation Blood Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Celgene Corporation Blood Preparation Product Portfolio Table 101. Celgene Corporation Recent Development Table 102. Bristol-Myers Squibb Company Company Information Table 103. Bristol-Myers Squibb Company Business Overview Table 104. Bristol-Myers Squibb Company Blood Preparation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Bristol-Myers Squibb Company Blood Preparation Product Portfolio Table 106. Bristol-Myers Squibb Company Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Blood Preparation Distributors List Table 110. Blood Preparation Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Blood Preparation Product Image Figure 2. Global Blood Preparation Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Preparation Sales Value (2021-2032) & (US$ Million) Figure 4. Global Blood Preparation Sales (2021-2032) & (k units) Figure 5. Global Blood Preparation Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Blood Preparation Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Blood Components Image Figure 10. Whole Blood Image Figure 11. Blood Derivatives Image Figure 12. Global Blood Preparation Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Blood Preparation Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Blood Preparation Sales Volume Share by Type (2021-2032) Figure 15. Global Blood Preparation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Blood Preparation Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Blood Preparation Sales Value Share by Type (2021-2032) Figure 18. Thrombocytosis Image Figure 19. Angina Blood Vessel Complications Image Figure 20. Renal Impairment Image Figure 21. Pulmonary Embolism Image Figure 22. Others Image Figure 23. Global Blood Preparation Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Blood Preparation Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Blood Preparation Sales Volume Share by Application (2021-2032) Figure 26. Global Blood Preparation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Blood Preparation Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Blood Preparation Sales Value Share by Application (2021-2032) Figure 29. Global Blood Preparation Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Blood Preparation Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Blood Preparation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Blood Preparation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Blood Preparation Sales Value (2021-2032) & (US$ Million) Figure 34. North America Blood Preparation Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Blood Preparation Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Blood Preparation Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Blood Preparation Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Blood Preparation Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Blood Preparation Sales Value (2021-2032) & (US$ Million) Figure 40. South America Blood Preparation Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Blood Preparation Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Blood Preparation Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Blood Preparation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Blood Preparation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Blood Preparation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Blood Preparation Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Blood Preparation Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Components
  • Whole Blood
  • Blood Derivatives
Applications
  • Thrombocytosis
  • Angina Blood Vessel Complications
  • Renal Impairment
  • Pulmonary Embolism
  • Others
Companies covered
  • Pfizer
  • GlaxoSmithKline
  • Baxter Healthcare Corp
  • AstraZeneca
  • Sanofi Aventis
  • Leo Pharma
  • Celgene Corporation
  • Bristol-Myers Squibb Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Blood Preparation Sales Value (2021-2032)
  4. 1.2.2 Global Blood Preparation Sales Volume (2021-2032)
  5. 1.2.3 Global Blood Preparation Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Blood Preparation Market Dynamics
  1. 2.1 Blood Preparation Industry Trends
  2. 2.2 Blood Preparation Industry Drivers
  3. 2.3 Blood Preparation Industry Opportunities and Challenges
  4. 2.4 Blood Preparation Industry Restraints
3 Blood Preparation Market by Company
  1. 3.1 Global Blood Preparation Company Revenue Ranking in 2025
  2. 3.2 Global Blood Preparation Revenue by Company (2021-2026)
  3. 3.3 Global Blood Preparation Sales Volume by Company (2021-2026)
  4. 3.4 Global Blood Preparation Average Price by Company (2021-2026)
  5. 3.5 Global Blood Preparation Company Ranking (2024-2026)
  6. 3.6 Global Blood Preparation Company Manufacturing Base and Headquarters
  7. 3.7 Global Blood Preparation Company Product Type and Application
  8. 3.8 Global Blood Preparation Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Blood Preparation Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Blood Preparation Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Blood Preparation Market by Type
  1. 4.1 Blood Preparation Type Introduction
  2. 4.1.1 Blood Components
  3. 4.1.2 Whole Blood
  4. 4.1.3 Blood Derivatives
  5. 4.2 Global Blood Preparation Sales Volume by Type
  6. 4.2.1 Global Blood Preparation Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Blood Preparation Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Blood Preparation Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Blood Preparation Sales Value by Type
  10. 4.3.1 Global Blood Preparation Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Blood Preparation Sales Value by Type (2021-2032)
  12. 4.3.3 Global Blood Preparation Sales Value Share by Type (2021-2032)
5 Blood Preparation Market by Application
  1. 5.1 Blood Preparation Application Introduction
  2. 5.1.1 Thrombocytosis
  3. 5.1.2 Angina Blood Vessel Complications
  4. 5.1.3 Renal Impairment
  5. 5.1.4 Pulmonary Embolism
  6. 5.1.5 Others
  7. 5.2 Global Blood Preparation Sales Volume by Application
  8. 5.2.1 Global Blood Preparation Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Blood Preparation Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Blood Preparation Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Blood Preparation Sales Value by Application
  12. 5.3.1 Global Blood Preparation Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Blood Preparation Sales Value by Application (2021-2032)
  14. 5.3.3 Global Blood Preparation Sales Value Share by Application (2021-2032)
6 Blood Preparation Regional Sales and Value Analysis
  1. 6.1 Global Blood Preparation Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Preparation Sales by Region (2021-2032)
  3. 6.2.1 Global Blood Preparation Sales by Region: 2021-2026
  4. 6.2.2 Global Blood Preparation Sales by Region (2027-2032)
  5. 6.3 Global Blood Preparation Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Blood Preparation Sales Value by Region (2021-2032)
  7. 6.4.1 Global Blood Preparation Sales Value by Region: 2021-2026
  8. 6.4.2 Global Blood Preparation Sales Value by Region (2027-2032)
  9. 6.5 Global Blood Preparation Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Blood Preparation Sales Value (2021-2032)
  12. 6.6.2 North America Blood Preparation Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Blood Preparation Sales Value (2021-2032)
  15. 6.7.2 Europe Blood Preparation Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Blood Preparation Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Blood Preparation Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Blood Preparation Sales Value (2021-2032)
  21. 6.9.2 South America Blood Preparation Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Blood Preparation Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Blood Preparation Sales Value Share by Country, 2025 VS 2032
7 Blood Preparation Country-level Sales and Value Analysis
  1. 7.1 Global Blood Preparation Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blood Preparation Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Blood Preparation Sales by Country (2021-2032)
  4. 7.3.1 Global Blood Preparation Sales by Country (2021-2026)
  5. 7.3.2 Global Blood Preparation Sales by Country (2027-2032)
  6. 7.4 Global Blood Preparation Sales Value by Country (2021-2032)
  7. 7.4.1 Global Blood Preparation Sales Value by Country (2021-2026)
  8. 7.4.2 Global Blood Preparation Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Blood Preparation Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Blood Preparation Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Blood Preparation Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Blood Preparation Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Blood Preparation Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Blood Preparation Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Blood Preparation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Blood Preparation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Blood Preparation Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Blood Preparation Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Blood Preparation Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Blood Preparation Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Blood Preparation Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Blood Preparation Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Blood Preparation Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Blood Preparation Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Blood Preparation Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Blood Preparation Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Blood Preparation Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Blood Preparation Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Blood Preparation Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Blood Preparation Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Blood Preparation Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Blood Preparation Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Blood Preparation Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Blood Preparation Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Blood Preparation Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Blood Preparation Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Blood Preparation Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Blood Preparation Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Blood Preparation Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Blood Preparation Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Blood Preparation Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Blood Preparation Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Blood Preparation Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Blood Preparation Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Blood Preparation Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Blood Preparation Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Blood Preparation Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Blood Preparation Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Blood Preparation Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Blood Preparation Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Blood Preparation Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Blood Preparation Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Blood Preparation Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Blood Preparation Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Blood Preparation Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Blood Preparation Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Blood Preparation Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Blood Preparation Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Blood Preparation Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Blood Preparation Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Blood Preparation Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Blood Preparation Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Blood Preparation Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Blood Preparation Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Blood Preparation Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Blood Preparation Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Blood Preparation Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Blood Preparation Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Blood Preparation Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Blood Preparation Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Blood Preparation Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Blood Preparation Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Blood Preparation Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Blood Preparation Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Blood Preparation Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Blood Preparation Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Blood Preparation Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Blood Preparation Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Blood Preparation Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Blood Preparation Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Blood Preparation Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Blood Preparation Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Blood Preparation Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Blood Preparation Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Blood Preparation Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Blood Preparation Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Blood Preparation Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Blood Preparation Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Blood Preparation Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Blood Preparation Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Blood Preparation Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Blood Preparation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Blood Preparation Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Blood Preparation Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 GlaxoSmithKline
  8. 8.2.1 GlaxoSmithKline Company Information
  9. 8.2.2 GlaxoSmithKline Business Overview
  10. 8.2.3 GlaxoSmithKline Blood Preparation Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Blood Preparation Product Portfolio
  12. 8.2.5 GlaxoSmithKline Recent Developments
  13. 8.3 Baxter Healthcare Corp
  14. 8.3.1 Baxter Healthcare Corp Company Information
  15. 8.3.2 Baxter Healthcare Corp Business Overview
  16. 8.3.3 Baxter Healthcare Corp Blood Preparation Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Baxter Healthcare Corp Blood Preparation Product Portfolio
  18. 8.3.5 Baxter Healthcare Corp Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Blood Preparation Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Blood Preparation Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Sanofi Aventis
  26. 8.5.1 Sanofi Aventis Company Information
  27. 8.5.2 Sanofi Aventis Business Overview
  28. 8.5.3 Sanofi Aventis Blood Preparation Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Aventis Blood Preparation Product Portfolio
  30. 8.5.5 Sanofi Aventis Recent Developments
  31. 8.6 Leo Pharma
  32. 8.6.1 Leo Pharma Company Information
  33. 8.6.2 Leo Pharma Business Overview
  34. 8.6.3 Leo Pharma Blood Preparation Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Leo Pharma Blood Preparation Product Portfolio
  36. 8.6.5 Leo Pharma Recent Developments
  37. 8.7 Celgene Corporation
  38. 8.7.1 Celgene Corporation Company Information
  39. 8.7.2 Celgene Corporation Business Overview
  40. 8.7.3 Celgene Corporation Blood Preparation Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Celgene Corporation Blood Preparation Product Portfolio
  42. 8.7.5 Celgene Corporation Recent Developments
  43. 8.8 Bristol-Myers Squibb Company
  44. 8.8.1 Bristol-Myers Squibb Company Company Information
  45. 8.8.2 Bristol-Myers Squibb Company Business Overview
  46. 8.8.3 Bristol-Myers Squibb Company Blood Preparation Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bristol-Myers Squibb Company Blood Preparation Product Portfolio
  48. 8.8.5 Bristol-Myers Squibb Company Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Blood Preparation Value Chain Analysis
  2. 9.1.1 Blood Preparation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Blood Preparation Sales Mode & Process
  6. 9.2 Blood Preparation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Blood Preparation Distributors
  9. 9.2.3 Blood Preparation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst